（文章来源：证券日报） 证券日报网讯广生堂8月1日在互动平台回答投资者提问时表示，公司专注于药品的研发、生产与销售， 未经营特种气体业务。 ...

新华财经上海8月1日电（林郑宏） 随着A股7月行情收官，当月A股涨幅榜也正式出炉。 得益于创新药板块的大幅上扬，排除7月上市的新股后，广生堂（300436.SZ）以218.94%的涨幅位居A股月内涨幅榜次席，仅次于"一月十倍"的现象级个股 上纬新材（688585.SH）。 连亏四年，股价飙升？ 广生堂全名为福建广生堂药业股份有限公司，于2015年4月22日在深交所上市。 中经社行业洞察产业服务数据平台（简称"行业洞察系统"）显示，广生堂是专注于肝病及抗病毒、抗感染治疗药物领域的国家重点高新技术企业，也是拥有 五大抗乙肝病毒临床用药的企业。公司坚持从传统仿制药企向创新药企转型的发展战略，持续引进和开发一类创新药和高端仿制药。公司下设多个子业务单 元，畅销品种十几款，涵盖肝病、男科、心血管、中成药等领域。 | 序号 | 发布日期 ◆ | 资质类别 | 资质名称 | 认定年度 ⇒ | | --- | --- | --- | --- | --- | | 1 | 2025-01-07 | 专精特新中小企业 | 省级专精特新中小企业 | 2025 | | 2 | 2024-12-30 | 高新技术企业 | 国家级高新技术 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002940 | 昂利康 | 62.92 | 10.00% | 11.62万 | 7.17亿 | | 601089 | 福元医药 | 26.54 | 9.99% | 10.13万 | 2.68 亿 | | 600774 | 汉商集团 | 12.46 | 9.97% | 31.00万 | 3.72亿 | | 002370 | 亚太药业 | 7.40 | 9.96% | 309.35万 | 22.01亿 | | 002437 | 营衡药业 | 4.04 | 8.89% | 482.38万 | 19.13 Z | | 300966 | 并同药业 | 26.68 | 8.41% | 29.78万 | 8.08亿 | | 688658 | 倪康药业 | 33.79 | 7.82% | 16.60万 | 5.72亿 | | 688091 | 上海谊众 | 77.63 | 7.79% | 12.47万 | 9.36 Z | | 600513 | 联环药业 | 4 ...

格隆汇8月1日丨广生堂(300436.SZ)在互动平台表示，我司专注于药品的研发、生产与销售，未经营特 种气体业务。 ...

Core Viewpoint - The stock of Fujian Guangshengtang Pharmaceutical Co., Ltd. has experienced significant price fluctuations, with a cumulative increase of over 30% from July 29 to July 31, 2025, despite the company's continuous losses over the past three years and the uncertainty surrounding its innovative drug development [2][4][6]. Group 1: Stock Performance and Market Reaction - The company's stock price has deviated significantly, with a cumulative increase of over 30% during the specified trading days, indicating abnormal trading activity [2][4]. - As of July 30, 2025, the company's latest price-to-book ratio is 46.58, which is substantially higher than the industry average of 3.17 for the pharmaceutical manufacturing sector [2]. Group 2: Financial Performance - The company has reported continuous losses over the last three years and the first quarter of 2025, with net profits attributed to shareholders being -127.40 million, -348.59 million, -156.30 million, and -28.49 million respectively [2][6]. Group 3: Drug Development Updates - The company announced the successful enrollment of the first subject in the Phase III clinical trial for its innovative hepatitis B treatment, GST-HG141, on July 26, 2025. However, this does not guarantee market approval and is not expected to have a significant impact on the company's financial performance in the short term [3][5]. - The drug development process is lengthy and costly, with high risks associated with technology, approval, and policy factors, leading to uncertainties regarding the potential for market approval [3][6].

Key Points - Tibet Tourism may apply for suspension of trading if significant abnormalities occur in stock transactions [1] - Southern Road Machinery's stock price has deviated from its fundamental situation [1] - Industrial Fulian's major customers and products have not undergone significant changes [1] - Yingweike has established a relatively complete liquid cooling technology and product solution capability [1] - Victory Energy's operational situation remains normal with no significant changes in the internal and external business environment [1] - Qizheng Tibetan Medicine's operational situation is normal with no significant changes in the internal and external business environment [1] - Dongxin Co. states that its investment in Shanghai Lishuan's chip products is not applicable for large model computing clusters [1] - Guosheng Co. has obtained project filing related to PEEK from its wholly-owned subsidiary [1] - Action Education's actual controller proposed a mid-term dividend of 10 yuan per 10 shares [1] Mergers and Acquisitions - Darui Electronics plans to acquire 80% of Weiste's equity through capital increase and share acquisition [1] - Dashengda intends to acquire 30% equity of Thailand's Far East [1] Financing - Aoshikang plans to issue convertible bonds not exceeding 1 billion yuan for high-end printed circuit board projects [1] - Sixuan New Materials intends to raise no more than 466 million yuan through a private placement [1] - Changhua Chemical plans to raise no more than 230 million yuan for a carbon dioxide polyether project [1] Share Buybacks and Reductions - Fuanna plans to repurchase shares worth between 55.85 million and 104 million yuan [1] - Jiangnan Yifan's board member intends to increase his stake in the company [1] - Jieya Co. and its concerted parties plan to reduce their holdings by no more than 4.95% [1] - Other companies including Tongda Co., Haohan Deep, and Wanhu Chemical also plan to reduce their holdings [1] Operational Data - Sinopec expects a net profit decline of 39.5% to 43.7% year-on-year for the first half of the year [1] - Qingdao Bank reported a net profit of 3.065 billion yuan for the first half, up 16.05% year-on-year [1] - Daodaquan's net profit increased by 563.15% year-on-year, proposing a dividend of 1.76 yuan per 10 shares [1] - Zhengdan Co. reported a net profit increase of 120.35% year-on-year, proposing a dividend of 3 yuan per 10 shares [1] - Other companies reported varying profit changes, including losses and significant increases [1] Contracts and Major Investments - Sanhui Electric signed a framework contract for robot equipment sales [1] - Zhejiang University Network New's subsidiary won a smart engineering project worth 94.2712 million yuan [1] - New Aluminum Times plans to invest no less than 500 million yuan in a project for lightweight, high-strength auto parts [1] - Zhishang Technology will use part of its raised funds for a smart manufacturing production base in Vietnam [1]

证券代码：300436 证券简称：广生堂 公告编号：2025054 福建广生堂药业股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 月 29 日至 7 月 31 日连续三个交易日收盘价格涨幅偏离值累计超过 30%。根据《深 圳证券交易所交易规则》规定，属于股票交易异常波动的情况。根据中证指数有 限公司最新数据显示，截至 2025 年 7 月 30 日，公司的最新市净率为 46.58；公 司所属中上协行业分类"医药制造业（C27）"的最新市净率为 3.17。公司市净 率与同行业的情况有较大差异。公司股价短期内大幅上涨，但公司基本面未发生 重大变化，可能存在股价大幅上涨后回落的风险，郑重提醒广大投资者注意公司 股票二级市场交易风险，理性决策，谨慎投资。 度归属于上市公司股东的净利润分别为-12,740.39 万元、-34,858.98 万元、 -15,630.44 万元，-2,848.89 万元。敬请广大投资者注意投资风险，谨慎决策。 GST-HG141 的 III 期临床试验首例受试者成功入组的公告》 （公告编号：2025053）， 公司 ...

Group 1 - Dazhengda plans to acquire 30% equity in Thailand Far East for a total consideration of 204 million Thai Baht, with an additional capital increase of 670 million Thai Baht post-acquisition [4] - Fuanan intends to repurchase shares worth between 55.85 million to 104 million Yuan for employee stock ownership plans or equity incentive plans, with a maximum repurchase price of 11 Yuan per share [7] - Siquan New Materials plans to raise no more than 466 million Yuan through a private placement, with proceeds allocated to various projects including a heat dissipation product project in Vietnam [10] Group 2 - Zhengdan Co. reported a net profit of 630 million Yuan for the first half of 2025, a year-on-year increase of 120.35%, and proposed a cash dividend of 3 Yuan per 10 shares [11] - Darui Electronics plans to acquire 80% of Weiste's equity through capital increase and share purchase, aiming to enhance its strategic layout in lightweight materials [12] - Shandong Highway intends to participate in a capital increase project for Weihai Bank, with a total investment not exceeding 348 million Yuan [2] Group 3 - Ankai Micro plans to launch the AK1037 series low-power lock control SoC chip designed for smart locks, featuring high integration and low power consumption [3] - Industrial Fulian announced that its main customers and products have not undergone significant changes despite recent stock price fluctuations [5] - Zhishang Technology will invest 180 million Yuan of its excess fundraising into building a smart manufacturing base in Vietnam to expand its product line and capacity [9]

Group 1 - Dazhengda plans to acquire 30% equity in Thailand Far East for a total consideration of 204 million Thai Baht, with an additional capital increase of 670 million Thai Baht [1][3] - Fuanan intends to repurchase shares worth between 55.85 million and 104 million yuan for employee stock ownership plans or equity incentive plans, with a maximum repurchase price of 11 yuan per share [1][6] - Siquan New Materials plans to raise no more than 466 million yuan through a private placement, with proceeds allocated to various projects including a cooling product project in Vietnam [1][8] Group 2 - Zhengdan Co. reported a 120.35% year-on-year increase in net profit for the first half of the year, with a proposed cash dividend of 3 yuan per 10 shares [1][9] - Darui Electronics plans to acquire 80% of Weiste's equity through capital increase and share purchase, aiming to enhance its strategic layout in lightweight materials [1][10] - Shandong Highway intends to participate in a capital increase project for Weihai Bank, with a total investment not exceeding 348 million yuan [2] Group 3 - Ankai Micro plans to launch a low-power lock control SoC chip series designed for smart locks, featuring high integration and low power consumption [3] - Industrial Fulian announced that its main customers and products have not undergone significant changes, despite recent stock price fluctuations [4] - Zhishang Technology will invest 180 million yuan of over-raised funds into a smart manufacturing base in Vietnam to expand its product line and capacity [1][7] Group 4 - Aoxin plans to issue convertible bonds not exceeding 1 billion yuan for high-end printed circuit board projects [1][11] - Dalian Friendship reached a settlement in a lawsuit with its controlling shareholder, with the case being withdrawn from court [1][12]

Group 1 - The State Council issued opinions on enhancing care services for severely disabled individuals, emphasizing increased policy support and infrastructure development [3] - The National Development and Reform Commission (NDRC) held a meeting to discuss the construction of a unified national market and promote healthy development of the private economy [3][4] - The Ministry of Commerce addressed the sale of overseas port assets by CK Hutchison Holdings, stating that the Chinese government will conduct legal reviews to protect market competition and national interests [3][4] Group 2 - The manufacturing PMI for July was reported at 49.3%, a decrease of 0.4 percentage points from the previous month, influenced by seasonal factors [5] - The non-manufacturing business activity index and composite PMI output index were 50.1% and 50.2%, respectively, both remaining above the critical point despite declines [5] - The implementation of the Anti-Money Laundering and Counter-Terrorism Financing Management Measures for precious metals and gemstones took effect on August 1, requiring reporting for cash transactions over 100,000 yuan [5] Group 3 - The World Gold Council reported that global gold demand reached 1,249 tons in Q2 2025, a 3% year-on-year increase, driven by gold ETF investments [5] - Gold ETF inflows in Q2 amounted to 170 tons, contrasting with outflows in the same period of 2024, with Asia contributing 70 tons [5] - The total gold ETF demand for the first half of 2025 reached 397 tons, the highest since 2020 [5] Group 4 - Shenzhen's Development and Reform Commission outlined a plan for high-quality construction of low-altitude infrastructure, aiming to establish over 1,200 takeoff and landing points by the end of 2026 [6][7] - The plan includes the opening of over 1,000 low-altitude commercial flight routes and aims for significant coverage of urban areas with low-altitude services [6][7] Group 5 - Xizang Tourism announced it may apply for a trading suspension if significant stock trading anomalies continue [9] - Southern Road Machinery's stock price has diverged from its fundamentals, prompting attention [9] - Industrial Fulian reported no significant changes in major customers or products [9]